An α2-adrenergic receptor antagonist (Kd = 2.6 µM) and an L-type calcium channel blocker (IC50 = 17 µM) well-known for its coronary vasodilator effects; inhibits K-Ras plasma membrane localization (IC50 = 9.64 µM), blocking the proliferation of K-Ras-transformed tumor cells.